Risk Communication During COVID-19
Abrams, E. and Greenhawt, M. (2020). Risk Communication During COVID-19. Journal of Allergy Clinical Immunology Practice, 8(6):1711-1794.
The authors discuss risk communication during the COVID-19 pandemic. They emphasize that when infection rates and morbidity are high and there is an absence of therapeutic medications, as was the case early in the pandemic, effective risk communication is important to avoid the public stockpiling countermeasures such as medications or personal protective equipment. The authors recommend using social media and a consistent media presence to inform patients and colleagues of risks.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments